These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28686777)

  • 1. Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.
    Draelos ZD; Rodriguez DA; Kempers SE; Bruce S; Peredo MI; Downie J; Chang-Lin JE; Berk DR; Ruan S; Kaoukhov A
    J Drugs Dermatol; 2017 Jun; 16(6):591-598. PubMed ID: 28686777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: Second of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-Controlled Trials.
    Eichenfield LF; Lain T; Frankel EH; Jones TM; Chang-Lin JE; Berk DR; Ruan S; Kaoukhov A
    J Drugs Dermatol; 2016 Aug; 15(8):962-9. PubMed ID: 27537997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials.
    Stein Gold LF; Jarratt MT; Bucko AD; Grekin SK; Berlin JM; Bukhalo M; Weiss JS; Berk DR; Chang-Lin JE; Lin V; Kaoukhov A
    J Drugs Dermatol; 2016 May; 15(5):553-61. PubMed ID: 27168264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype.
    Taylor SC; Cook-Bolden FE; McMichael A; Downie JB; Rodriguez DA; Alexis AF; Callender VD; Alvandi N
    J Drugs Dermatol; 2018 Feb; 17(2):160-167. PubMed ID: 29462223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable.
    Tanghetti E; Harper JC; Oefelein MG
    J Drugs Dermatol; 2012 Dec; 11(12):1417-21. PubMed ID: 23377510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
    Tanghetti E; Harper J; Baldwin H; Kircik L; Bai Z; Alvandi N
    J Drugs Dermatol; 2018 Nov; 17(11):1192-1198. PubMed ID: 30500139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evidence for the role of a topical anti-inflammatory agent in comedonal acne: findings from a randomized study of dapsone gel 5% in combination with tazarotene cream 0.1% in patients with acne vulgaris.
    Tanghetti E; Dhawan S; Green L; Ling M; Downie J; Germain MA; Kasteler JS; Kircik L; Oefelein MG; Draelos Z
    J Drugs Dermatol; 2011 Jul; 10(7):783-92. PubMed ID: 21720661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
    Tanghetti E; Harper J; Baldwin H; Kircik L; Bai Z; Alvandi N
    J Drugs Dermatol; 2018 Nov; 17(11):1192-1198. PubMed ID: 30500141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females.
    Tanghetti E; Harper J; Baldwin H; Kircik L; Bai Z; Alvandi N
    J Drugs Dermatol; 2018 Nov; 17(11):1192-1198. PubMed ID: 30500140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: a 12-week, randomized, double-blind study.
    Fleischer AB; Shalita A; Eichenfield LF; Abramovits W; Lucky A; Garrett S;
    J Drugs Dermatol; 2010 Jan; 9(1):33-40. PubMed ID: 20120423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapsone 7.5% Gel: A Review in Acne Vulgaris.
    Al-Salama ZT; Deeks ED
    Am J Clin Dermatol; 2017 Feb; 18(1):139-145. PubMed ID: 28005194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cohort study on the treatment with dapsone 5% gel of mild to moderate inflammatory acne of the face in women.
    Lynde CW; Andriessen A
    Skinmed; 2014; 12(1):15-21. PubMed ID: 24720080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris.
    Draelos ZD; Carter E; Maloney JM; Elewski B; Poulin Y; Lynde C; Garrett S;
    J Am Acad Dermatol; 2007 Mar; 56(3):439.e1-10. PubMed ID: 17208334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris.
    Jarratt MT; Jones TM; Chang-Lin JE; Tong W; Berk DR; Lin V; Kaoukhov A
    J Drugs Dermatol; 2016 Oct; 15(10):1250-1259. PubMed ID: 27741344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of dapsone gel 5% for the treatment of acne vulgaris in adolescents.
    Raimer S; Maloney JM; Bourcier M; Wilson D; Papp K; Siegfried E; Garrett S;
    Cutis; 2008 Feb; 81(2):171-8. PubMed ID: 18441772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
    Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Experience With Once-Daily Dapsone Gel, 7.5% Monotherapy in Patients With Acne Vulgaris.
    Stockton TC; Tanghetti EA; Lain E; Zeichner JA; Alvandi N
    J Drugs Dermatol; 2018 Jun; 17(6):602-608. PubMed ID: 29879247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: Effective Acne Therapy Regardless of Age or Gender.
    Stein Gold L; Werschler WP; Mohawk J
    J Drugs Dermatol; 2017 Jun; 16(6):582-589. PubMed ID: 28686776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.